Skip to content

Search

Project helps Ethan belong

Ethan recently took part in Belong, a study led by The Kids which aims to ensure deaf and hard of hearing kids have a happy & positive school experience

Aboriginal Ear Health Stakeholder Meeting (By invitation only)

Acknowledging the enormous efforts in ear health programs across WA, we invite stakeholders to assist us in establishing research priorities.

Homes crucial for healthy ears

The Kids researchers discovered that overcrowding is the strongest predictor of carriage of bacteria that cause otitis media

DOWNLOAD - The first research report: Patterns and trends in Mortality in WA.

The Advisory Council on the Prevention of Deaths of Children and Young People today officially released this report.

Aboriginal researcher receives Fiona Stanley Medal

Aboriginal researcher Annette Stokes has been awarded the Fiona Stanley Medal for her commitment to improving child health and wellbeing.

Children with otitis media mount a pneumococcal serotype specific serum IgG and IgA response comparable to healthy controls after pneumococcal conjugate vaccination

We investigated the suggestion that otitis-prone children have an impaired antibody response in the context of pneumococcal vaccination.

Genetic susceptibility to otitis media in childhood

Reviewed in this article these studies have identified positive association at 21 genes with association at five of these replicated in independent populations.

IgG Responses to Pneumococcal and Haemophilus Influenzae Protein Antigens Are Not Impaired in Children with a History of Recurrent Acute Otitis Media

Vaccines including conserved antigens from Streptococcus pneumoniae & nontypeable Haemophilus influenzae have the potential to reduce of otitis media.

FBXO11, a regulator of the TGFΒ pathway, is associated with severe otitis media in Western Australian children

Otitis media (OM) is a common childhood disease characterised by middle ear inflammation following infection

Predominance of nontypeable haemophilus influenzae in children with otitis media

In Australia the 7-valent pneumococcal conjugate vaccine (PCV7) is administered at 2, 4 and 6 months of age, with no booster dose.